ClinicalTrials.Veeva

Menu

Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia (CroyAid-SCZ)

U

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

DSM-5 Schizophrenia

Study type

Observational

Funder types

Other

Identifiers

NCT03471013
2017-A02271-52 (Other Identifier)
CHU-384

Details and patient eligibility

About

Only one third of patients with schizophrenia are observant to their treatment knowing that the lack of adherence to treatment is one of the most important predictors of relapse.

Recent work shows that the erroneous or negative beliefs of patients with schizophrenia regarding antipsychotic treatment are associated with poor compliance.

The hypothesis is that negative beliefs about the antipsychotic treatment of caregivers of patients with schizophrenia may be associated with a higher risk of poor compliance compared to caregivers with positive beliefs about treatment.

The primary purpose is to explore the correlation between caregiver beliefs about treatment and patient compliance, taking into account the level of caregiver-patient link.

Full description

Non-interventional cross-sectional exploratory study with a single visit for patients with schizophrenia and their caregivers, who agreed to participate in the protocol.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years old
  • With a diagnosis of schizophrenia according to DSM-5 criteria
  • Accompanied by his main caregiver, who will be able to complete the questionnaires after having signed the information form.
  • Treated with one or more antipsychotics.
  • Able to complete the questionnaires related to the protocol
  • Having agreed to sign the information form.

Exclusion criteria

  • Not understanding French, unable to answer questions linguistically
  • Presenting an organic pathology and / or cognitive deterioration likely to hinder a good understanding of the interview
  • Having already participated in the study
  • presenting disorders related to the use of substances of severe intensity (such as acute intoxication, withdrawal syndrome or any state of delirium)

Trial design

150 participants in 1 patient group

Patients and caregivers
Description:
Patients suffering from schizophrenia accompanied by their caregiver

Trial contacts and locations

1

Loading...

Central trial contact

Patrick LACARIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems